Plain-English translation of NCT06047301 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a supportive program called Pathways designed to help people with advanced lung cancer maintain hope and pursue personal goals while undergoing treatment. The study compares Pathways against an enhanced care approach that provides education about managing common side effects like pain and fatigue, plus information about supportive resources. Researchers want to see whether focusing on hope and goal-setting improves mental health and quality of life.
Advanced lung cancer is a difficult diagnosis, and people undergoing treatment often struggle with anxiety, depression, and loss of purpose. This trial exists to explore whether helping patients build hope and stay connected to their personal goals can improve their emotional well-being and overall quality of life during this challenging time.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either the Pathways program or the enhanced usual care group. You'll complete surveys about your mood, goals, and quality of life at the beginning, midway through, at the end of the program, and again at 6 and 12 weeks after finishing. The Pathways program focuses on building hope and helping you identify and pursue meaningful personal goals during your treatment. Participation involves completing surveys and, if assigned to Pathways, engaging with the hope-building intervention alongside your regular cancer treatment.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States